Ruscogenin treatment significantly relieved FA-induced AKI, improved kidney function indicators, restored the expression of SLC7A11 and HO-1 and suppressed the FA-induced upregulation of Rev-erbα/β. This evidence concerns the gene HMOX1 and acute kidney injury.